Federal award
DIASORIN INC
W91YTZ21P0051
Contract
Obligated and Ceiling
- Obligated (net)
- $247,355.03
- Ceiling (potential value, not spending)
- $247,355.03
- Current value
- $247,355.03
- Gross positive obligations
- $342,038.78
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- DIASORIN INC · FGK2QR959BV5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- DIASORIN S.P.A. · KN6PH2K51SJ6
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTZ
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ21P0051
- Award type code
- B
- Actions
- 17 · Feb 25, 2021 to Jun 11, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History17
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 11, 2025 | FY2025 | P00016 | B | $1,352.00 | — |
| Apr 29, 2025 | FY2025 | P00015 | B | $13,797.32 | — |
| Feb 6, 2025 | FY2025 | P00014 | C | −$21,786.11 | — |
| Dec 19, 2024 | FY2025 | P00013 | C | −$20,859.81 | — |
| Nov 14, 2024 | FY2025 | P00012 | M | $0.00 | — |
| Oct 15, 2024 | FY2025 | P00011 | C | $67,249.10 | — |
| Aug 2, 2024 | FY2024 | P00010 | G | $0.00 | — |
| Jan 22, 2024 | FY2024 | P00009 | C | −$3,756.47 | — |
| Oct 10, 2023 | FY2024 | P00008 | C | $67,249.10 | — |
| Apr 17, 2023 | FY2023 | P00007 | G | $0.00 | — |
| Nov 28, 2022 | FY2023 | P00006 | C | −$20,373.18 | — |
| Oct 12, 2022 | FY2023 | P00005 | C | $67,249.10 | — |
| Apr 7, 2022 | FY2022 | P00004 | G | $0.00 | — |
| Dec 14, 2021 | FY2022 | P00003 | C | −$27,908.18 | — |
| Oct 26, 2021 | FY2022 | P00002 | C | $67,249.10 | — |
| Sep 2, 2021 | FY2021 | P00001 | G | $0.00 | — |
| Feb 25, 2021 | FY2021 | 0 | — | $57,893.06 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.